GSK plc GSK
Set alert
49.13 USD -0.38 -0.77%
At close · Nov 2
49.36 +0.23 +0.47%
After hours · Nov 2, 4:00 PM ET
48.91 Day range 49.50
45.81 52-week range 61.70
- YTD
- +0.18%
- 1 year
- +4.84%
- Open
- 49.17
- Prev close
- 49.51
- Mkt cap
- 98.43B
- Vol
- 2.65M
- Avg vol
- 4.08M
- EPS
- 2.87
- P/E
- 17.12
- Div yield
- 3.67%
More statistics
- Low
- 48.91
- High
- 49.50
- Forward P/E
- 9.91
- Beta
- 0.28
- Short ratio
- 2.86
- Inst. own
- 17.46%
- Dividend
- 1.82
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 3, 2027
- 50-d avg
- 49.43
- 200-d avg
- 52.34
- 1y target
- 59.12
5D chart
Events in this range
- Oct 28, 2026Earnings: 1.47; estimate 1.33; surprise 10.53%
- Oct 29, 2026Downgrade: Jefferies · Buy → Hold
Signals (81)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 19 hours ago |
| RSI: Oversold | Nov 2, 9:30 AM | 19 hours ago |
| SMA: Bearish | Oct 30, 2:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:30 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:25 PM | 3 days ago |
| RSI: Overbought | Oct 30, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:35 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 10:15 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:05 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 4 days ago |
| RSI: Overbought | Oct 29, 3:45 PM | 4 days ago |
| RSI: Overbought | Oct 29, 3:35 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 4 days ago |
Newest 20 of 81.
Analyst view
Consensus: hold
Hold
Price target (mean) 59.12 +20.3% upside
Now 49.13
- Target (low)
- 49.00
- Target (mean)
- 59.12
- Target (high)
- 70.00
Ratings (0m) 9 3 buy · 5 hold · 1 sell
- Strong buy1
- Buy2
- Hold5
- Sell1
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.73676 | 0.72585 – 0.74766 | 0.69843 | +5.5% | 8.87B | +2.9% | 2 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 4.76 | 4.72 – 4.80 | 4.71 | +1.1% | 33.84B | +3.6% | 4 |
| Next year | 4.96 | 4.83 – 5.15 | 4.76 | +4.1% | 35.37B | +4.5% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Jefferies | Downgrade | Buy | Hold |
| Jan 6, 2026 | Barclays | Downgrade | Equal-Weight | Underweight |
| Nov 12, 2024 | Jefferies | Downgrade | Buy | Hold |
| Oct 31, 2024 | Guggenheim | Downgrade | Buy | Neutral |
| Jul 8, 2024 | UBS | Downgrade | Buy | Neutral |
| Jul 2, 2024 | Jefferies | Maintained | Buy | Buy |
| May 30, 2024 | Goldman Sachs | Initiated | — | Neutral |
| Mar 4, 2024 | Guggenheim | Upgrade | Neutral | Buy |
| Jan 23, 2024 | Morgan Stanley | Initiated | — | Equal-Weight |
| Jan 3, 2024 | Jefferies | Upgrade | Hold | Buy |